Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verheijen

Showing results (931-940 of 1,005) with videos related to

Pageof 101
Sort By:
Investigational New Drugs|October 14, 2020
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancerJin-Ji Yang, Jian Fang, Yong-Qian Shu, et al.
ACS Applied Nano Materials|February 1, 2024
Low Surface Recombination in Hexagonal SiGe Alloy Nanowires: Implications for SiGe-Based NanolasersWilhelmus J H Willem-Jan Berghuis, Marvin A J van Tilburg, Wouter H J Peeters, et al.
Trials|February 20, 2026
The RECLAIM adaptive platform trial for the evaluation of treatments for post-COVID condition in the Netherlands: core protocolJanneke H H M van de Wijgert, Julie M H Schoevers, Todd D Swarthout, et al.
The New England Journal of Medicine|September 8, 2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerIgnace Vergote, Claes G Tropé, Frédéric Amant, et al.
Brain : a Journal of Neurology|January 21, 2009
Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA)F Mochel, F Sedel, A Vanderver, et al.
Human Mutation|February 19, 2013
Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease)Yu Sun, Rowida Almomani, Guido J Breedveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Sentinel node dissection is safe in the treatment of early-stage vulvar cancerAte G J Van der Zee, Maaike H Oonk, Joanne A De Hullu, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Antimicrobial Resistance and Infection Control|June 17, 2020
Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trialTessa Mulder, Marjolein Kluytmans-van den Bergh, Bart Vlaminckx, et al.
International Journal of Cancer|April 1, 2004
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 womenNicole W J Bulkmans, Lawrence Rozendaal, Peter J F Snijders, et al.
Pageof 101

Showing results (931-940 of 1,005) with videos related to

Sort By:
Pageof 101
Investigational New Drugs|October 14, 2020
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancerJin-Ji Yang, Jian Fang, Yong-Qian Shu, et al.
ACS Applied Nano Materials|February 1, 2024
Low Surface Recombination in Hexagonal SiGe Alloy Nanowires: Implications for SiGe-Based NanolasersWilhelmus J H Willem-Jan Berghuis, Marvin A J van Tilburg, Wouter H J Peeters, et al.
Trials|February 20, 2026
The RECLAIM adaptive platform trial for the evaluation of treatments for post-COVID condition in the Netherlands: core protocolJanneke H H M van de Wijgert, Julie M H Schoevers, Todd D Swarthout, et al.
The New England Journal of Medicine|September 8, 2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerIgnace Vergote, Claes G Tropé, Frédéric Amant, et al.
Brain : a Journal of Neurology|January 21, 2009
Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA)F Mochel, F Sedel, A Vanderver, et al.
Human Mutation|February 19, 2013
Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease)Yu Sun, Rowida Almomani, Guido J Breedveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Sentinel node dissection is safe in the treatment of early-stage vulvar cancerAte G J Van der Zee, Maaike H Oonk, Joanne A De Hullu, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Antimicrobial Resistance and Infection Control|June 17, 2020
Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trialTessa Mulder, Marjolein Kluytmans-van den Bergh, Bart Vlaminckx, et al.
International Journal of Cancer|April 1, 2004
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 womenNicole W J Bulkmans, Lawrence Rozendaal, Peter J F Snijders, et al.
Pageof 101